ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2319

High Prevalence of Asymptomatic Vertebral Fractures in Inflammatory Myositis

Latika Gupta, Sukesh Edavalath, Ramnath Misra and Able Lawrence, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fractures and myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Muscle Biology, Myositis and Myopathies - Poster II: Clinical

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with inflammatory myositis have increased prevalence of symptomatic fractures. Early detection of asymptomatic vertebral fractures may help in their prevention. We studied the frequency of asymptomatic vertebral fracture and its risk factors in inflammatory myositis.

Methods: Adults with inflammatory myositis were included and dorsal and lumbar spine lateral radiographs were taken. The scoring was done using Genant’s semi-quantitative method. Besides demographic data, weight, height, postmenopausal status, duration of corticosteroid use, anticonvulsants, calcium supplements, and other co-morbidities like diabetes or hypothyroidism and past history of non-vertebral fracture were recorded. Bone mineral density was done using DEXA. Myositis Damage Index (MDI) was also assessed. All results are expressed in median and IQR.

Results: 100 patients (82 females) with myositis of age 35.5 (28.5-46) years and disease duration 3 (1.81-8.0) years were studied. Twenty patients were postmenopausal women. 35 patients had adult dermatomyositis (DM), 26 each had polymyositis and 26 connective tissue disease associated myositis and 13 had juvenile onset myositis. Forty-six patients had asymptomatic vertebral fractures. 19 patients had more than one fracture. Half the fractures occurred in those with disease <5 years. Of the 69 fractures, 47 (68.1%) were mild, 16 (23.2%) were moderate and 6 (8.7%) were severe. 11th and 12th thoracic vertebrae were most commonly affected. Of the 67 patients who underwent BMD assessment, 62.7% were osteopenic and 26.9% were osteoporotic. T scores of DEXA scan at the lower third of the radius correlated negatively with fracture number (r=-0.27 (-0.50 to -0.005), p=0.04). Gender, age, duration of disease, intake of corticosteroid or calcium, BMI, menopausal status, or MDI had no correlation with number of fractures.  

Conclusion: Patients with inflammatory myositis have high prevalance of asymptomatic vertebral fractures.


Disclosure: L. Gupta, None; S. Edavalath, None; R. Misra, None; A. Lawrence, None.

To cite this abstract in AMA style:

Gupta L, Edavalath S, Misra R, Lawrence A. High Prevalence of Asymptomatic Vertebral Fractures in Inflammatory Myositis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/high-prevalence-of-asymptomatic-vertebral-fractures-in-inflammatory-myositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-prevalence-of-asymptomatic-vertebral-fractures-in-inflammatory-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology